Agenus (AGEN) Current Deferred Revenue (2010 - 2026)
Agenus (AGEN) posted quarterly Current Deferred Revenue of $1.1 million for Q1 2026, up 8064.29% year-over-year from $14000.0 in Q1 2025, and little changed quarter-over-quarter from $1.1 million in Q4 2025.
Agenus (AGEN) Current Deferred Revenue (2010 - 2026) Analysis & Trends
Agenus' Current Deferred Revenue history runs 17 years deep, the most recent figure standing at $1.1 million for Q1 2026.
- In Q1 2026, Current Deferred Revenue rose 8064.29% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $1.1 million (up 8064.29% YoY), while the FY2025 annual figure was $1.1 million, down 2.64% from the prior year.
- Current Deferred Revenue for Q1 2026 stood at $1.1 million, roughly flat from $1.1 million in the prior quarter.
- The five-year high for Current Deferred Revenue was $14.2 million in Q2 2022, with the low at $9000.0 in Q2 2024.
- The 5-year median for Current Deferred Revenue is $1.2 million (2023), against an average of $5.0 million.
- The sharpest annual moves came in 2024 and 2026: Current Deferred Revenue slumped 99.9% in 2024, then jumped 8064.29% in 2026.
- Agenus' Current Deferred Revenue stood at $12.3 million in 2022, then tumbled by 90.54% to $1.2 million in 2023, then rose by 1.12% to $1.2 million in 2024, then slipped by 2.64% to $1.1 million in 2025, then changed by 0.0% to $1.1 million in 2026.
- Business Quant data shows AGEN's Current Deferred Revenue at $1.1 million in Q1 2026, $1.1 million in Q4 2025, and $45000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Agenus | 311.95 Mn | 286.43 Mn | 34.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.14 Mn |
| Mar 31, 2026 | 1.14 Mn |
| Dec 31, 2025 | 1.14 Mn |
| Sep 30, 2025 | 45,000.00 |
| Jun 30, 2025 | 45,000.00 |
| Mar 31, 2025 | 14,000.00 |
| Dec 31, 2024 | 1.17 Mn |
| Sep 30, 2024 | 1.15 Mn |
| Jun 30, 2024 | 9,000.00 |
| Mar 31, 2024 | 13,000.00 |
| Dec 31, 2023 | 1.16 Mn |
| Sep 30, 2023 | 6.14 Mn |
| Jun 30, 2023 | 8.97 Mn |
| Mar 31, 2023 | 11.03 Mn |
| Dec 31, 2022 | 12.27 Mn |
| Sep 30, 2022 | 12.76 Mn |
| Jun 30, 2022 | 14.20 Mn |
| Mar 31, 2022 | 13.53 Mn |
| Dec 31, 2021 | 23.63 Mn |
| Sep 30, 2021 | 19.68 Mn |